← Insider buys
MCRB

Seres Therapeutics, Inc. · Healthcare

President and CEO Roger Pomerantz sold $238K of Seres Therapeutics, Inc.

Sold$238,291
$9.15Price
26,056Shares
−10%Stake

What MCRB did after the filing

Prices for MCRB after this filing aren't in yet.

Traded Thu, Jun 28. Filed Fri, Jun 29, 5:12 PM ET, after the close. Not investment advice.